Catalog |
name |
Description |
price |
R-R-4367 |
(-)-GSK598809 hydrochloride CAS No.863766-31-8 |
(-)-GSK598809/CAS No.863766-31-8 is an isomer of GSK598809. GSK598809 is a potent and selective dopamine D3 Receptor (DRD3) antagonist. |
price> |
R-R-4368 |
Ro 10-5824 dihydrochloride CAS No.189744-94-3 |
Ro 10-5824 dihydrochloride/CAS No.189744-94-3 is a selective dopamine D4 receptor partial agonist, with Ki of 5.2 nM. |
price> |
R-C-2569 |
Zotepine CAS:26615-21-4 |
Zotepine,an antipsychotic agent,is a potent antagonist of 5-HT2A,5-HT2C,Histamine H1,α1-adrenergic and Dopamine D2 receptors,with Kds of 2.6nM,3.2nM,3.3nM,7.3nM and 8nM,respectively.Zotepine exhibits antidepressive and anxiolytic effects in vivo. |
price> |
R-R-4369 |
Pentiapine CAS No.81382-51-6 |
Pentiapine (CGS 10746)/CAS No.81382-51-6 is a dopamine release inhibitor without binding to synaptic dopamine receptor sites. |
price> |
R-R-4370 |
NMI 8739 CAS No.129024-87-9 |
NMI 8739/CAS No.129024-87-9 is a dopamine D2 autoreceptor agonist, which is an amine conjugate of the DHA carrier and the neurotransmitter dopamine. |
price> |
R-R-4371 |
L-DOPA-d6 CAS No.713140-75-1 |
L-DOPA-d6/CAS No.713140-75-1 is the deuterium labeled L-DOPA. L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain. |
price> |
R-R-4372 |
Odapipam CAS No.131796-63-9 |
Odapipam (NNC 756)/CAS No.131796-63-9 is a selective, high affinity and benzazepine dopamine D1 receptor antagonist with a Kd of 0.18 nM. Odapipam is also a superior positron emission tomography (PET) radiotracer. |
price> |
R-R-4373 |
Preclamol hydrochloride CAS No.88768-67-6 |
Preclamol hydrochloride ((-)-3-PPP hydrochloride)/CAS No.88768-67-6 is a selective dopamine autoreceptor agonist. Preclamol hydrochloride has the potential for the research of schizophrenia. |
price> |
R-R-4374 |
Etilevodopa hydrochloride CAS No.39740-30-2 |
Etilevodopa (L-Dopa ethyl ester) hydrochloride/CAS No.39740-30-2, an ethyl-ester proagent of Levodopa, is rapidly hydrolyzed to Levodopa and ethanol by nonspecific esterases in the gastrointestinal tract. Etilevodopa hydrochloride is used for the treatment of Parkinson disease (PD). Levodopa is the direct precursor of dopamine and is a suitable proagent as it facilitates CNS penetration and delivers dopamine. |
price> |
R-R-4375 |
GBR 12783 dihydrochloride CAS No.67469-75-4 |
GBR 12783 dihydrochloride/CAS No.67469-75-4 is a specific, potent and selective dopamine uptake inhibitor that inhibits the [3H]dopamine uptake by rat and mice striatal synaptosomes with IC50s of 1.8 nM and 1.2 nM, respectively. GBR 12783 dihydrochloride can improve memory performance and increase hippocampal acetylcholine release in rats. |
price> |